Combined Dupilumab and House Dust Mite Sublingual Immunotherapy Provides Sustained Clinical and Immunologic Benefits in Severe Atopic Dermatitis: 3-Year Results of a Randomized Controlled Study

The Journal of Allergy and Clinical Immunology: In Practice · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles